authors
- Wong, Peggy PC
- Kariminia, Amina
- Jones, David
- Eaves, Connie J
- Foley, Ronan
- Ivison, Sabine
- Couban, Stephen
- Schultz, Kirk R
Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- June 21, 2018
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1114 Paediatrics and Reproductive Medicine (FoR)
- Adolescent (MeSH)
- Adult (MeSH)
- Allografts (MeSH)
- Benzylamines (MeSH)
- CD56 Antigen (MeSH)
- Cyclams (MeSH)
- Graft vs Host Disease (MeSH)
- Hematopoietic Stem Cell Mobilization (MeSH)
- Heterocyclic Compounds (MeSH)
- Humans (MeSH)
- Immunology (Science Metrix)
- Killer Cells, Natural (MeSH)
- Middle Aged (MeSH)
- Young Adult (MeSH)
published in
- Blood Journal